Canna Boot Camp Spring 2023 with Alex Hoggan

The second part of this column will take a look at specific examples in the public domain of elemental contamination of cannabis consumer products, which shows that other elements are worthy of consideration and should be a part of the regulatory framework.

In light of recent headlines concerning cannabis laboratories throughout the country, Cannabis Science and Technology reached out to Douglas Duncan, Laboratory Director of Kairos Labs in Detroit, MI and member of our Editorial Advisory Board for more information. In this interview, Duncan shares his perspectives on lab shopping, major challenges in the industry today, and innovations in cannabis testing laboratories for the future. He also shares insights into consumer practices and the potential effects of a federal rescheduling of cannabis.

The first part of this column examines the fractured nature of state-based regulations and compares it with the federal limits for pharmaceutical products and dietary supplements.

Let’s take a look at the most recent webinars on cannabis research and medicine to catch up on industry trends and innovations.

The latest webinar from the GMP Collective discussed the practice of lab shopping and the various causes, effects, and potential solutions.

Live from the Cannabis Science Conference, Julie Kowalski shares her perspective on the conference.